Latest News of APG
APi Group Corporation (APG): A Bull Case Theory
By Yahoo! Finance |
3 days ago
APi Group Corp. is a leader in industrial services with a strong focus on fire safety through acquisitions and recurring revenue. Their inspection-led model drives high-margin services, with a strateg...
Does APi Group (APG) Have a Clear Path To Drive Organic Growth?
By Yahoo! Finance |
2 weeks ago
SouthernSun Asset Management's Q3 2024 investor letter showcased the success of its SMID Cap Strategy, outperforming indexes. APi Group Corporation (NYSE:APG) was highlighted as a top pick with impres...
An Intrinsic Calculation For APG|SGA SA (VTX:APGN) Suggests It's 39% Undervalued
By Yahoo! Finance |
2 weeks ago
APG|SGA's stock may not be reflecting its true value, as competitors trade at a smaller discount. Using a two-stage DCF model, future cash flows are estimated and discounted to present value to determ...
-
Is APi Group Corporation (APG) the Most Undervalued Industrial Stock to Buy According to Analysts?
By Yahoo! Finance | 1 month agoThe article discusses the industrial sector's growth potential and focuses on APi Group Corporation (NYSE:APG) as one of the undervalued stocks. APG expects positive margins from acquisitions and targ...
-
Insider Sale: CFO Jane Henderson Sells 6,000 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 2 months agoJane Henderson, CFO of Apogee Therapeutics Inc, sold 6,000 shares at $48.26 each on August 23, 2024. The company focuses on developing therapies for diseases with unmet medical needs. Henderson now ho...
-
Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoApogee Therapeutics, Inc. is a biotechnology company focusing on developing biologics for conditions like atopic dermatitis, asthma, and COPD. Their primary products are extended half-life monoclonal ...
-
Insider Sale: Carl Dambkowski Sells 7,335 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 3 months agoApogee Therapeutics Inc focuses on developing innovative treatments for medical conditions. An insider recently sold shares worth $298,464.45, adding to a trend of insider selling. Investors should co...
-
Apogee Therapeutics Inc (APGE) CEO Michael Henderson Sells 40,000 Shares
By Yahoo! Finance | 3 months agoApogee Therapeutics Inc CEO, Michael Henderson, sold 40,000 shares at $40.62 each, totaling $1.62 million. With 1,434,487 shares left, the company focuses on innovative therapies....
-
Should You Hold APi Group (APG)?
By Yahoo! Finance | 3 months agoGreystone Capital Management's Q2 2024 investor letter showcased returns ranging from +4.3 to +7.1%, with a median account return of +6.0%. The firm's strategy focuses on small companies, unlike major...
-
What Makes APi Group (APG) a Worthy Investment?
By Yahoo! Finance | 3 months agoLaughing Water Capital's Q2 2024 investor letter discusses a 2.5% return for Class A interests, focusing on hidden market corners. Highlighted stock, APi Group Corporation (NYSE:APG), saw a 28.99% gai...
-
SAP SE (SAPGF) Stock Price, News, Quote & History
By Yahoo! Finance | 3 months agoSAP SE is a global provider of applications, technology, and services, offering a range of solutions including SAP S/4HANA, SAP SuccessFactors, spend management solutions, customer experience solution...
-
Autonomous AI workers that talk to each other will arrive in 2025, Capgemini predicts
By CNBC | 3 months agoBy 2025, Capgemini predicts that artificial intelligence-powered agents will collaborate in a multi-agent AI system to solve tasks collectively. These agents function independently and execute tasks w...
-
SSE and APG progress on 2GW Netherlands offshore wind project
By Yahoo! Finance | 4 months agoSSE and APG are developing the 2GW IJmuiden Ver Alpha offshore wind project in the Netherlands to supply 7% of the country's electricity needs....
-
Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 4 months agoOn July 5, 2024, Apogee Therapeutics Inc's CEO sold 15,000 shares, now owning 1,474,487 shares. The company focuses on autoimmune disease treatments. Valued at $2.143 billion, recent insider transacti...
-
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 4 months agoOn July 3, 2024, Carl Dambkowski, CMO of Apogee Therapeutics Inc (NASDAQ:APGE), sold 5,995 shares. The company focuses on developing medical treatments....